Therapeutic effects of dipolar aprotic substances on Niemann-Pick cells.
Sakuragawa
N
N
Sato
M
M
Kamo
I
I
Arima
M
M
D000081:Acetamides / Q000627:therapeutic use; D002478:Cells, Cultured; D003451:Cryoprotective Agents / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D008782:Methylurea Compounds / Q000627:therapeutic use; D009542:Niemann-Pick Diseases / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D012867:Skin / Q000201:enzymology / Q000473:pathology; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D013454:Sulfoxides / Q000627:therapeutic use
D000081:Acetamides; D003451:Cryoprotective Agents; D008782:Methylurea Compounds; D013454:Sulfoxides; D010727:Phosphoric Diester Hydrolases; D013108:Sphingomyelin Phosphodiesterase; C013959:dimethylacetamide; C014026:hexamethylene bisacetamide; C002352:methylurea